BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24498881)

  • 1. A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.
    Pradella LM; Evangelisti C; Ligorio C; Ceccarelli C; Neri I; Zuntini R; Amato LB; Ferrari S; Martelli AM; Gasparre G; Turchetti D
    BMC Cancer; 2014 Feb; 14():70. PubMed ID: 24498881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
    Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
    PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
    Li X; Zhang R; Liu Z; Li S; Xu H
    Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
    PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
    Lynch ED; Ostermeyer EA; Lee MK; Arena JF; Ji H; Dann J; Swisshelm K; Suchard D; MacLeod PM; Kvinnsland S; Gjertsen BT; Heimdal K; Lubs H; Møller P; King MC
    Am J Hum Genet; 1997 Dec; 61(6):1254-60. PubMed ID: 9399897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Germline
    Lopez C; Abuel-Haija M; Pena L; Coppola D
    Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.
    Singh G; Odriozola L; Guan H; Kennedy CR; Chan AM
    BMC Cancer; 2011 Nov; 11():490. PubMed ID: 22103913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
    Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
    Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.
    Dominguez-Valentin M; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    Fam Cancer; 2018 Jan; 17(1):141-153. PubMed ID: 28608266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer.
    Chandarlapaty S; Sakr RA; Giri D; Patil S; Heguy A; Morrow M; Modi S; Norton L; Rosen N; Hudis C; King TA
    Clin Cancer Res; 2012 Dec; 18(24):6784-91. PubMed ID: 23092874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variant.
    Ouedraogo SY; Zoure AA; Zeye MMJ; Kiendrebeogo TI; Zhou X; Sawadogo AY; Simpore J; Chen H
    Mol Genet Genomics; 2022 Sep; 297(5):1257-1268. PubMed ID: 35731312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
    Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
    J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome.
    Salo-Mullen EE; Shia J; Brownell I; Allen P; Girotra M; Robson ME; Offit K; Guillem JG; Markowitz AJ; Stadler ZK
    Fam Cancer; 2014 Sep; 13(3):459-67. PubMed ID: 24609522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation.
    Reifenberger J; Rauch L; Beckmann MW; Megahed M; Ruzicka T; Reifenberger G
    Br J Dermatol; 2003 May; 148(5):1040-6. PubMed ID: 12786840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
    Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
    Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.